Conflict of interest [GxP / QC / QA]

posted by Norah – Tunisia, 2018-01-18 11:04 (2681 d 20:25 ago) – Posting: # 18202
Views: 5,009

I know that my question is weird, but to avoid COI in a bioequivalence study conducted in a center belonging to a pharmaceutical company, I need to establish the cases of fraud (possible frauds to influence the results in favor of the pharmaceutical lab) in order to prevent them ( implement preventive actions ), can you please help me to find what are the possibilities of fraud?
thank you

Complete thread:

UA Flag
Activity
 Admin contact
23,424 posts in 4,927 threads, 1,679 registered users;
72 visitors (0 registered, 72 guests [including 18 identified bots]).
Forum time: 08:29 CEST (Europe/Vienna)

Pharmacokinetics may be simply defined as
what the body does to the drug,
as opposed to pharmacodynamics, which may be defined as
what the drug does to the body.    Leslie Z. Benet

The Bioequivalence and Bioavailability Forum is hosted by
BEBAC Ing. Helmut Schütz
HTML5